Zydus Life To Acquire French Orthopedics Firm Amplitude Surgical For Rs 2,851 Crore
Zydus Lifesciences Ltd. on Tuesday announced it will acquire French orthopedics company Amplitude Surgical SA for 300 million euros or around Rs 2,851 crore.
The board approved a put open agreement, share purchase agreement, and other agreements to acquire 85.6% stake in Amplitude Surgical for 6.25 euros per equity share, aggregating to 256.8 million euros, according to an exchange filing.
Zydus Life will make a mandatory offer to buy shares via a simplified cash tender offer for the balance 14.4% stake for 43.2 million euros.
Listed in Paris, Amplitude Surgical's last traded price was 3.46 euros. Post-acquisition, the company will be delisted.
The deal is expected to be completed after regulatory approvals by June 2025.
Amplitude Surgical is involved in design, development, and marketing of products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery, aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery.
The proposed acquisition will execute Zydus Life's global MedTech strategy and a natural extension for its proven track record in life sciences and wellness segments, the filing said.
"In Amplitude Surgical, we see several medium-term and long-term growth opportunities with respect to portfolio, capabilities, manufacturing and geographies," said Managing Director Sharvil Patel.
In fiscal year ended June 30, 2024, Amplitude Surgical generated sales of 106.0 million euros.
Zydus Life Share Price Movement
Zydus Life share price advanced 1.25% intraday to Rs 904.9 apiece.
Zydus Life share price advanced 1.25% intraday to Rs 904.9 apiece. The scrip was trading 0.86% higher by 1:50 p.m. The benchmark NSE Nifty 50 was up 0.14%.
The stock has fallen 7.4% in the last 12 months and 9.3% on a year-to-date basis. The relative strength index was at 46.
Seventeen of the 33 analysts tracking Zydus Life have a 'buy' rating on the stock, 10 recommend a 'hold' and six suggest a 'sell', according to Bloomberg data. The average of 12-month analysts' price target of Rs 1,099 implies a potential upside of 22%.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
